loader2
Login Open ICICI 3-in-1 Account
Open ICICI 3-in-1 Account

BSE 250 SmallCap Index Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Gujarat Mineral Development Corporation Ltd. 17 Nov 2025 12:49 PM
Result PDF

Q2FY26 Quarterly Result Announced for Gujarat Mineral Development Corporation Ltd.

Coal & Mining company Gujarat Mineral Development Corporation announced Q2FY26 results

  • Revenue from Operations stood at Rs 528 crore as against Rs 593 crore in Q2FY25, primarily reflecting lower lignite offtake.
  • EBITDA stood at Rs 182 crore versus Rs 203 crore in the corresponding quarter last year, with an EBITDA margin of 29% (vs 31% in Q2FY25), indicating continued operating efficiency in a softer topline environment.
  • Other Income increased to Rs 109 crore (vs Rs 62 crore in Q2FY25), aiding overall profitability.
  • The Company recorded an Exceptional Income of Rs 474 crore on account of write-back of GST Input Tax Credit, recognised during the quarter.
  • As a result, Profit Before Tax (PBT) for the quarter stood at Rs 634 crore, as compared to Rs 183 crore in Q2FY25.

Roopwant Singh, IAS, Managing Director, GMDC, said: “This quarter reflects a stable performance for GMDC. Seasonal monsoon conditions had a limited impact on mining activity, yet operations remained largely consistent. The one-time GST input has strengthened the quarterly financials, but our focus continues to remain on operational discipline and long-term value creation. We are steadily advancing our mining initiatives, improving productivity and supporting Gujarat’s and India’s industrial requirements in a reliable and responsible manner.”

Result PDF

Result PDF

Healthcare Facilities company Narayana Hrudayalaya announced Q2FY26 results

  • Consolidated total operating revenue was Rs 16,438 million for Q2FY26 as compared to Rs 13,667 million in the corresponding period of the previous year, reflecting a change of 20.3 % YoY and 9.1% QoQ.
  • Consolidated EBITDA stood at Rs 4,265 million, reflecting a margin of 25.9% as against Rs 3,323 million in Q2FY25, translating into a change of 28.3% YoY and 18.2% QoQ.
  • Consolidated PAT stood at Rs 2,583 million, reflecting a margin of 15.7% as compared to Rs 1,993 million in Q2FY25, translating into a change of 29.6% YoY and 31.7% QoQ.
  • India operating revenue was Rs 12,347 million for Q2FY26 as compared to Rs 11,351 million in the corresponding period of the previous year, reflecting a change of 8.8% YoY and 9.0% QoQ.
  • Cayman operating revenue was Rs 4,316 million for Q2FY26 as compared to Rs 2,423 million in the corresponding period of the previous year, reflecting a change of 78.1% YoY and 8.8% QoQ.

Emmanuel Rupert, Managing Director and Group CEO, Narayana Hrudayalaya, said: “The second quarter of the fiscal year has delivered a strong performance after a steady start to the year. We are pleased to report the highest-ever revenue and profitability at both India and the Group level. The performance improvement in India is attributable to strong growth in domestic footfall and improvements in payor mix, along with positive traction from our Clinics outreach, resulting in the highest ever profitability margins. Our hospital business in Cayman continues to deliver robust performance, with the Insurance business showing strong growth, resulting in record revenues for the region. We are confident that the synergies between the hospital and insurance businesses will deliver steady growth going forward in the Cayman region. The domestic Integrated Care business continues to be on a strong growth path, with our clinics garnering sizeable footfalls across all locations, providing a positive thrust to the overall business. After a steady start, our domestic Insurance business has shown strong momentum this quarter and we expect to build on this further going forward. We will continue to invest in this business and are optimistic that it will be a significant driver of growth to the NH ecosystem. We thank the investor community for their faith in us and remain confident of delivering on expectations for the year.”

Result PDF

Textiles company Trident announced Q2FY26 results

  • Consolidated Revenue for the quarter stood at Rs 1,803 crore.
  • Consolidated EBIDTA for the quarter stood at Rs 232 crore at 12.85%, as against EBITDA margin of 13.78 % YoY and 18.06% QoQ.
  • Consolidated Net Profit for the quarter stood at Rs 91 crore at 5.04%, as against Net Profit of 4.83% YoY and 8.10% QoQ.
  • Net Debt stands at Rs 847 crore on Sep 30, 2025 as compared to Rs 879 crore as on June 30, 2025, a reduction of 32 crore.
  • Free Cash Flow stands at Rs 281 crore for Q2FY26.

Deepak Nanda, Managing Director, Trident, said, “As we reflect on Trident Limited’s Q2FY26 results, it's evident that amidst challenging macroeconomic conditions, our company has showcased quarter-on-quarter revenue growth. We have further strengthened our balance sheet by reducing net debt by Rs 32 crore and maintaining a healthy Debt Equity Ratio at 0.18. Furthermore, the Current Ratio is at 1.61 from 1.87 on quarter-on-quarter (Q-o-Q) basis.

Our focus on innovative product pipelines aligned with evolving consumer preferences, combined with new FTA between India & UK, positions us well to capitalize on emerging opportunities while remaining committed to sustainable growth and operational excellence.

Going forward, we shall continue focusing on improving our volumes, value added products and strengthening our domestic market. With this foundation, Trident Limited stands poised to continue its journey of sustainable growth and innovation in the ensuing period”.

Result PDF

Pharmaceuticals company Natco Pharma announced Q2FY26 results

  • Consolidated total revenue of Rs 1,463.0 crore for Q2FY26 as against Rs 1,434.9 crore as of 30th September 2024.
  • EBITDA (including other income) for the quarter was at Rs 679.2 crore with margins at 46.4%.
  • The net profit for the period, on a consolidated basis was Rs 517.9 crore.
  • The Board of Directors have declared an interim dividend of Rs 1.5 per equity share of Rs 2 each during Q2FY26.

Result PDF

Hotels company Ventive Hospitality announced Q2FY26 results

  • Consolidated Revenue of Rs 554 crore , a growth of 28% YoY.
  • Consolidated EBITDA was at Rs 255 crore, a growth of 50% YoY.
  • Consolidated EBITDA margin was at 46%, an expansion of 7 percentage points.

Ranjit Batra, Chief Executive Officer, said: “Our second quarter performance marks four consecutive quarters of strong sustained growth since listing with record EBITDA growth of 50% in this quarter. Our diversified, luxury-focused portfolio, disciplined execution and strategic asset expansion position us well for continued revenue and margin growth in the coming quarters.

We remain committed to our strategic objective of doubling our key count over the next five years, supported by targeted acquisitions and organic expansion. Our latest acquisition of the Hilton Goa Resort and proposed investment in Soho House India further augment our pipeline of 1,582 keys, and underscore our strategy to tap into new, vibrant market segments to power our long- term growth.”

Result PDF

Healthcare Facilities company Rainbow Childrens Medicare announced Q2FY26 results

  • Revenue: Rs 4,448.0 million against Rs 4,174.6 million during Q2FY25, change 6.5%.
  • EBITDA: Rs 1,488.7 million against Rs 1,470.8 million during Q2FY25, change 1.2%.
  • EBITDA Margin: 33.5% for Q2FY26.
  • PAT: Rs 756.2 million against Rs 790.1 million during Q2FY25, change -4.3%.
  • PAT Margin: 17.0% for Q2FY26.

Ramesh Kancharla, Chairman & Managing Director of Rainbow Children’s Medicare, said: “While Q2 was seasonally softer, it was also a quarter of strategic progress for Rainbow. We completed our first acquisition in the Northeast, launched Rainbow at Rajahmundry, and are set to open two more hospitals in Bengaluru shortly. With a significant part of our expansion now complete, our focus will move toward strengthening business operations and driving sustainable growth across our network.”

Result PDF

IT Consulting & Software company Sonata Software announced Q2FY26 results

  • Revenue for Q2FY26 stood at Rs 2,119.3 crore, a decline of 28.5% QoQ.
  • EBITDA (before other income and forex) for Q2FY26 stood at 8.1%, 280 bps accretion QoQ.
  • PAT for Q2FY26 stood at Rs 120.2 crore, growth of 10.0% QoQ.
  • Cash and cash equivalents (gross) stood at Rs 323 crore.
  • Cash and cash equivalents (net) stood at negative Rs 280 crore.
  • ROCE stood at 22.1% in Q2FY26, compared to 18.5% in Q1FY26.
  • RONW stood at 27.1% in Q2FY26, compared to 24.0% in Q1FY26.
  • The Company has declared its second interim dividend for the financial year at Rs 1.25 per share. This is in line with the commitment made during the previous earnings call to implement a quarterly interim dividend payout policy starting this year.

Samir Dhir, MD & CEO of Sonata Software, said: “International IT Services reported steady progress during the quarter, consolidated PAT improving by 10% QoQ. The business secured a large deal in the healthcare vertical with a leading provider, reaffirming our focus on driving growth through large deals and consistent execution. Our continued strategic investments in Artificial Intelligence are delivering results, with AI-led orders accounting for approximately 10% of the overall order book for the quarter. As clients accelerate AI-enabled modernization to enhance competitiveness, we remain confident in the company’s long-term growth trajectory.”

Sujit Mohanty, MD & CEO, Sonata Information Technology, said: “We continue to execute on our three-pillar strategy focused on driving growth in the Microsoft SMC sector, expanding our AI-led partnerships with ISVs, and securing large system integration deals. During the quarter, we added new clients across all three pillars, with particularly strong traction in the Microsoft SMC segment. Despite prevailing industry headwinds in certain sectors, our disciplined execution and focused investments continue to position us well for sustained growth.”

Result PDF

Consumer Electronics company PG Electroplast announced Q2FY26 results

  • Revenues stood at Rs 655.37 crore, down 2.4% YoY.
  • EBITDA stood at Rs 44.68 crore vs Rs 60.54 crore in Q2FY25 – down 26.2%.
  • Net Profit for the quarter stood at Rs 2.38 crore, vs Rs 19.47 crore in Q2FY25.

Vikas Gupta, Managing Director, said: “Sales performance in the first half of FY26 was impacted by subdued demand in the Room AC segment, resulting in a moderated growth. However, underlying demand indicators remain healthy, and the recent reduction in GST rates is expected to enhance product affordability and accelerate category penetration over the medium term. Given the structurally low penetration of Room ACs in India, we continue to see significant headroom for sustained growth.

Capital efficiency continues to be a key operating principle, with all capital allocation decisions guided by sustainable profitability and value-accretive metrics. While near-term growth momentum may moderate, the medium to long-term outlook remains positive. The Company is committed to building a resilient, high-performing organization that consistently delivers superior returns and long-term stakeholder value.

The Company remains steadfast in its focus on research and development, product innovation, capital-efficient expansion, and strengthening strategic client partnerships. Ongoing investments in new platform development and capacity augmentation across core product categories are progressing as planned.”

Result PDF

Pharmaceuticals company Granules India announced Q2FY26 results

  • Revenue from Operations of Q2FY26 stood at Rs 12,970 million, a growth of 34% YoY across regions.
  • EBITDA: Rs 2,782 million against Rs 2,033 million during Q2FY25, change 37%.
  • EBITDA Margin: 21% for Q2FY26.
  • PBT: Rs 1,759 million against Rs 1,284 million during Q2FY25, change 37%.
  • PAT: Rs 1,306 million against Rs 972 million during Q2FY25, change 34%.
  • PAT Margin: 10% for Q2FY26.

Krishna Prasad Chigurupati, Chairman & Managing Director, Granules India, said: “We are delighted to deliver a resilient financial performance with healthy growth in both revenue and profitability. The improvement in EBITDA and PAT reflects our continued focus on operational excellence, disciplined execution, and the strength of our governance. Our ongoing investments in R&D and talent underscore our commitment to innovation and long-term value creation. Our peptides CDMO platform through Ascelis, anchored in the legacy of Senn Chemicals in Switzerland, is steadily gaining visibility, with renewed customer interest and promising new discussions underway.”

Result PDF

Construction & Engineering company Afcons Infrastructure announced Q2FY26 results

  • Total Income: Rs 3,101 crore against Rs 3,090 crore during Q2FY25, change 0.4%.
  • EBITDA: Rs 401 crore against Rs 427 crore during Q2FY25, change -6.1%.
  • EBITDA Margin: 12.9% for Q2FY26.
  • PAT: Rs 105 crore against Rs 135 crore during Q2FY25, change -22.4%.
  • PAT Margin: 3.4% for Q2FY26.
  • EPS: Rs 2.85 for Q2FY26.

Subramanian Krishnamurthy, Executive Chairman (Whole-time Director), said: “We delivered modest growth both in revenue and profitability during the first half of FY26, despite extended and intense monsoons.

In H1FY26, our total income reached Rs 6,520 crore representing a growth of 3.4% YoY. The EBITDA margin during the period expanded to 13.0%. Our profit after tax grew by 6.8% YoY. However, our Q2 performance was muted on the back of subdued order inflow and slower execution due to extended and harsh monsoons. Pending order book at the end of September 2025 was Rs 32,681 crore, which includes order inflow of Rs 1,268 crore received in H1FY26. With a healthy pipeline and considering Government’s capex plans we believe that the second-half will witness a robust uptick in our order book.

We extend our gratitude to Mr. Shapoorji Pallonji Mistry for his invaluable guidance and oversight as Chairman of the Board. His continued association as Chairman Emeritus will remain a source of strength as we strive to reinforce our position as a leading infrastructure-focused organization. The recent induction of Mr. Pallon Mistry, Mr. Firoz Cyrus Mistry, and Mr. Santosh Nayar to the Board marks an important step forward. Their insights will bring fresh perspectives that will support our long-term growth ambitions.

As we step into the second-half, our focus remains on disciplined execution and prudent financial management as we pursue sustainable growth and maintaining our profitability. We will continue to approach bidding and investment decisions with care, ensuring that shareholder value remains at the core of our strategy.”

Result PDF

Trending News

Saregama India's announced strategic partnership with, and investment in, Sanjay Leela Bhansali's Bhansali Productions

Saregama India's announced strategic partnership with, and investment in, Sanjay Leela Bhansali's Bhansali Productions

Published on 17-Dec-2025 09:01

The Competition Commission of India (CCI) has approved ITC’s acquisition of the paper and pulp manufacturing business of Aditya Birla Real Estate Ltd (ABREL).

The Competition Commission of India (CCI) has approved ITC’s acquisition of the paper and pulp manufacturing business of Aditya Birla Real Estate Ltd (ABREL)

Published on 17-Dec-2025 09:00

Zydus Lifesciences has received a USFDA acceptance for its ANDA of for copper histidinate (CUTX-101), intended to treat Menkes disease in pediatric patients.

Zydus Lifesciences has received a USFDA acceptance for its ANDA of for copper histidinate (CUTX-101), intended to treat Menkes disease in pediatric patients.

Published on 16-Dec-2025 09:05

KIMS has commenced operations at its newly established hospital located at the PES University campus in Electronic City, Bengaluru

Krishna Institute of Medical Sciences (KIMS) has commenced operations at its newly established hospital located at the PES University campus in Electronic City, Bengaluru

Published on 16-Dec-2025 09:03

Power Grid Corporation of India Ltd (POWERGRID) has been declared the successful bidder under Tariff-Based Competitive Bidding

Power Grid Corporation of India Ltd (POWERGRID) has been declared the successful bidder under Tariff-Based Competitive Bidding 

Published on 16-Dec-2025 09:01

Marico is in talks to acquire Cosmix, a startup that sells plant-based protein supplements

Marico is in talks to acquire Cosmix, a startup that sells plant-based protein supplements

Published on 16-Dec-2025 09:00

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Play Store App Store
market app
✕
Application status